Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Case Study: YourChoice Therapeutics
Download181 - 186 of 238 results
EBF 2021: Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
EBF 2021: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
AAPS 2021: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
ASCPT 2021 Poster: A First in Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
HBI-3000: A Novel Drug for Conversion of Atrial Fibrillation - Phase 1 Study Results
Stability Capabilities
Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.